## **Core Concept**
Scleroderma, also known as systemic sclerosis, is a chronic autoimmune disease characterized by **thickening and hardening of the skin** and involvement of various internal organs. It is associated with **vascular alterations** and **excessive collagen deposition**. The disease can be classified into two main forms: limited systemic sclerosis (lSSc) and diffuse systemic sclerosis (dSSc).

## **Why the Correct Answer is Right**
The question does not provide specific statements for options A, B, C, and D. However, to address the query effectively, we need to consider common false statements about scleroderma. Typically, true statements about scleroderma include its autoimmune nature, the presence of **antinuclear antibodies (ANA)**, and the potential for **organ involvement** such as the skin, lungs, kidneys, and gastrointestinal tract. A false statement might contradict these established facts.

## **Why Each Wrong Option is Incorrect**
Without specific details on the options, let's consider hypothetical scenarios:
- **Option A:** If it states that scleroderma is not an autoimmune disease, this would be incorrect because scleroderma is indeed characterized by an autoimmune response.
- **Option B:** If it suggests that scleroderma only affects the skin, this would be incorrect because, while skin involvement is a hallmark, the disease can also affect internal organs.
- **Option C:** If it claims that scleroderma is not associated with any specific autoantibodies, this would be incorrect as certain autoantibodies, like **anti-Scl-70 (anti-topoisomerase I)**, are associated with the disease.
- **Option D:** This would be evaluated based on its accuracy in relation to scleroderma.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Raynaud's phenomenon**, characterized by vasospasm of the fingers and toes in response to cold or stress, is often one of the earliest manifestations of scleroderma. Recognizing this can aid in the early diagnosis of the disease.

## **Correct Answer: D.**